Volume therapy with hydroxyethyl starches: Are we throwing the anesthesia baby out with the intensive care unit bathwater?

Anesthesia and Analgesia

Volumn 119, Issue 3, 2014, Pages 737-739

  Irwin, Michael G ^a   Gan, Tong J ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

ARTIFICIAL VENTILATION; BLEEDING; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; DRUG CONTRAINDICATION; ELECTIVE SURGERY; EUROPEAN MEDICINES AGENCY; FOOD AND DRUG ADMINISTRATION; HUMAN; INTENSIVE CARE UNIT; INTESTINE FUNCTION; KIDNEY INJURY; MOLECULAR WEIGHT; MORTALITY; NOTE; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PENETRATING TRAUMA; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEPSIS; SURGICAL PATIENT;

BLOOD VOLUME; DRUG INDUSTRY; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; HYPOVOLEMIA; INTENSIVE CARE; INTENSIVE CARE UNITS; KIDNEY DISEASES; META-ANALYSIS AS TOPIC; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS; PRODUCT RECALLS AND WITHDRAWALS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84906673546     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000221     Document Type: Note

References (28)

1. Hydroxyethyl starch solutions for infusion. Available at: Http:// www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/ human/referrals/ Hydroxyethyl-starch-containing-solutions/ human-referral-prac-000012. jsp&mid=WC0b01ac05805c516f. Accessed January 25, 2014
2. FDA Safety Communication: Boxed Warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. Available at: Http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/ucm358271. htm. Accessed January 25, 2014
3. Hydroxyethyl starch solutions should not be used in some critically ill patients. Available at: Http:// healthycanadians.gc.ca/ recall-Alert-rappel- Avis/hc-sc/2013/34299a-eng.php. Accessed January 25, 2014
4. November 25, 2013 Approval Letter-HESPAN® (6% Hetastarch in 0.9% Sodium Chloride injection). Available at: Http:// www.fda.gov/ biologicsbloodvaccines/bloodbloodproducts/ approvedproducts/ newdrugapplicationsndas/ucm376786. htm. Accessed January 25, 2014
5. PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients. Available at: Http://www.ema.europa.eu/ ema/index.jsp?curl=pages/news-And- events/news/2013/10/news-detail-001917.jsp&mid=WC0b01ac058004d5c1. Accessed January 25, 2014
6. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34
7. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11
8. Weiskopf RB. Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: If nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology 2013;119:1249-54
9. Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-Analysis. JAMA 2013;309:678-88
10. Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-Analysis and trial sequential analysis. BMJ 2013;346:f839
11. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S; CHEST Management Committee. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013;39:558-68
12. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013;2:CD000567
13. Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: Systematic review and meta-Analysis. Intensive Care Med 2013;39:811-22
14. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228
15. Chappell D, Jacob M. Hydroxyethyl starch-The importance of being earnest. Scand J Trauma Resusc Emerg Med 2013;21:61
16. Shaw AD, Kellum JA. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol 2013;8:497-503
17. Siddik SM, Aouad MT, Kai GE, Sfeir MM, Baraka AS. Hydroxyethylstarch 10% is superior to Ringer's solution for preloading before spinal anesthesia for Cesarean section. Can J Anesth 2000;47:616-21
18. Moretti EW, Robertson KM, El-Moalem H, Gan TJ. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg 2003;96:611-7
19. Ko JS, Kim CS, Cho HS, Choi DH. A randomized trial of crystalloid versus colloid solution for prevention of hypotension during spinal or low-dose combined spinal-epidural anesthesia for elective cesarean delivery. Int J Obstet Anesth 2007;16:8-12
20. Du XJ, Hu WM, Xia Q, Huang ZW, Chen GY, Jin XD, Xue P, Lu HM, Ke NW, Zhang ZD, Li QS. Hydroxyethyl starch resuscitation reduces the risk of intra-Abdominal hypertension in severe acute pancreatitis. Pancreas 2011;40:1220-5
21. Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002;97:820-6
22. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anesth 2011;107:693-702
23. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013;118:387-94
24. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013;116:35-48
25. Bagchi A, Eikermann M. Mashed potatoes and maize: Are the starches safe? Anesthesiology 2013;118:244-7
26. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, Preiser JC, Outin H, Troché G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Régnier J, Abroug F, Berger P, Clec'h C, Cousson J, Thibault L, Chevret S; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA 2013;310:1809-17
27. Assessment report for solutions for infusion containing hydroxyethyl starch. Available at: Http:// www.ema. europa.eu/docs/en-GB/document-library/ Referrals-document/ Hydroxyethyl-starch-containing-medicines-107/ Recommendation-provided-by-Pharmacovigilance-Risk-Assessment-Committee/ WC500154254.pdf. Accessed January 25, 2014
28. BMJ Open Data. Available at: Http://www.bmj.com/opendata. Accessed January 25, 2014.